Custom Health Holdings Inc. Stock: price and insider trades · Canada
Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Custom Health Holdings Inc. Buy (bullish), based on 1 analysts. Average price target: CA$12.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
- Rights Restricted Share UnitsTSXSEDI:4794563
- WarrantsTSXSEDI:4794051
- OptionsTSXSEDI:4794049
- Common SharesTSXSEDI:4794048
- WarrantsTSXSEDI:4794035
- OptionsTSXSEDI:4794034
- Common SharesTSXSEDI:4794033
- 5,000 shares@ CA$5.900.020% mcap12.9% of flowCommon SharesTSXSEDI:4793358Canonical exit: 18 Jan 2027 (T+90)
- 4,000 shares@ CA$7.250.016% mcap44.5% of flowCommon SharesTSXSEDI:4791020
- 10,000 shares@ CA$7.50100.0% of flowOptionsTSXSEDI:4779693
- OptionsTSXSEDI:4779692
- 50,000 sharesRights Restricted Share UnitsTSXSEDI:4779691
- Rights Restricted Share UnitsTSXSEDI:4779690
- 14,252 shares@ CA$2.570.021% mcap55.5% of flowCommon SharesTSXSEDI:4778124
- 27,596 sharesOptionsTSXSEDI:4778123
- 3,000 shares@ CA$7.470.015% mcap9.7% of flowCommon SharesTSXSEDI:4777583
- OptionsTSXSEDI:4777516
- WarrantsTSXSEDI:4777515
- Common SharesTSXSEDI:4777514
- 20,000 sharesOptionsTSXSEDI:4776832
- 2,000 shares@ CA$7.740.010% mcap6.7% of flowCommon SharesTSXSEDI:4775564
- 2,500 sharesCommon SharesTSXSEDI:4774165
- 2,700 shares@ CA$7.36110.011% mcap19.3% of flowCommon SharesTSXSEDI:4769001Canonical exit: 24 Nov 2026 (T+90)
- 3,500 shares@ CA$7.310.014% mcap24.8% of flowCommon SharesTSXSEDI:4768600Canonical exit: 23 Nov 2026 (T+90)
- 700 shares@ CA$7.000.0026% mcap4.8% of flowCommon SharesTSXSEDI:4768599Canonical exit: 22 Nov 2026 (T+90)
25 of 78 declarations
About Custom Health Holdings Inc.
All the reported activity of Custom Health Holdings Inc. sits in 2026: the 71 filings are published between June 4, 2026 and October 20, 2026, which covers the last twelve months. The Canadian health care company, with a market capitalisation of CAD 149.1 million and 1.9% held by insiders, shows 18 purchases worth EUR 169,678 (median EUR 9,023) and a single sale, EUR 18,244, by Andrew Aertker, a senior officer, on October 14, 2026. Purchases make up 95% of open-market trades.
Michael Castanho, a director and senior officer, signed 17 filings including 11 purchases, with EUR 18,668 on October 20, 2026 and EUR 17,880 on July 9, 2026. Kevin George Knight, a 10% security holder, has 13 filings including 7 purchases, the largest worth EUR 15,819 on August 25, 2026. From July 13, 2026 to August 12, 2026, 2 insiders bought EUR 26,543.
Read moreShow less
The other filings consist of 4 option exercises, 1 grant and 47 filings of another kind. Brent Theodore Herman, a senior officer, has 7 filings with no open-market trade. In all, 13 filers. Filings appear a median of 5 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
